ADDF STATEMENT ON FDA DECISION NOT TO GRANT ACCELERATED APPROVAL TO DONANEMAB FOR TREATMENT OF ALZHEIMER's DISEASE

Press/Media

Period20 Jan 2023 → 21 Jan 2023

Media coverage

89

Media coverage